2024 Q2 Form 10-Q Financial Statement

#000157694024000037 Filed on April 25, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $1.039B $948.5M
YoY Change 23.13% 25.97%
Cost Of Revenue $787.6M $725.6M
YoY Change 19.83% 20.66%
Gross Profit $251.9M $222.9M
YoY Change 34.72% 47.05%
Gross Profit Margin 24.23% 23.5%
Selling, General & Admin $126.0M $114.1M
YoY Change 19.84% 16.07%
% of Gross Profit 50.01% 51.18%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $5.690M $5.475M
YoY Change 57.14% 66.31%
% of Gross Profit 2.26% 2.46%
Operating Expenses $126.0M $114.1M
YoY Change 19.84% 16.07%
Operating Profit $125.9M $108.8M
YoY Change 53.82% 104.21%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $1.278M -$24.51M
YoY Change -109.75% -1735.98%
Pretax Income $110.6M $84.32M
YoY Change 60.93% 91.6%
Income Tax $26.90M $19.99M
% Of Pretax Income 24.31% 23.7%
Net Earnings $83.72M $64.33M
YoY Change 62.74% 93.13%
Net Earnings / Revenue 8.05% 6.78%
Basic Earnings Per Share $2.65 $2.02
Diluted Earnings Per Share $2.61 $2.00
COMMON SHARES
Basic Shares Outstanding 31.79M 31.77M
Diluted Shares Outstanding 32.09M 32.24M

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $106.7M $122.8M
YoY Change -69.56% -69.72%
Cash & Equivalents $106.7M $122.8M
Short-Term Investments
Other Short-Term Assets $404.3M $36.82M
YoY Change 1504.55% 27.33%
Inventory $3.295B $3.107B
Prepaid Expenses
Receivables $78.26M $66.00M
Other Receivables $0.00 $0.00
Total Short-Term Assets $3.885B $3.333B
YoY Change 18.0% 3.23%
LONG-TERM ASSETS
Property, Plant & Equipment $97.22M $74.65M
YoY Change 197.63% 126.07%
Goodwill $32.08M $32.08M
YoY Change 5.55% 5.55%
Intangibles
YoY Change
Long-Term Investments $28.49M $28.40M
YoY Change
Other Assets $62.25M $123.8M
YoY Change -0.37% 155.17%
Total Long-Term Assets $446.9M $778.8M
YoY Change -20.85% 60.79%
TOTAL ASSETS
Total Short-Term Assets $3.885B $3.333B
Total Long-Term Assets $446.9M $778.8M
Total Assets $4.331B $4.112B
YoY Change 12.31% 10.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $158.8M $135.8M
YoY Change 8.34% 27.47%
Accrued Expenses $271.8M $264.9M
YoY Change 2.06% 3.45%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change -100.0% -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $430.6M $409.1M
YoY Change -28.7% -20.26%
LONG-TERM LIABILITIES
Long-Term Debt $1.435B $1.282B
YoY Change 39.23% 24.9%
Other Long-Term Liabilities $979.0K
YoY Change -42.14%
Total Long-Term Liabilities $1.435B $1.283B
YoY Change 39.23% 24.79%
TOTAL LIABILITIES
Total Short-Term Liabilities $430.6M $409.1M
Total Long-Term Liabilities $1.435B $1.283B
Total Liabilities $1.866B $1.692B
YoY Change 14.13% 9.79%
SHAREHOLDERS EQUITY
Retained Earnings $1.925B $1.849B
YoY Change 17.74% 16.25%
Common Stock $540.9M $569.9M
YoY Change -7.88% -1.88%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.466B $2.419B
YoY Change
Total Liabilities & Shareholders Equity $4.331B $4.112B
YoY Change 12.31% 10.74%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $83.72M $64.33M
YoY Change 62.74% 93.13%
Depreciation, Depletion And Amortization $5.690M $5.475M
YoY Change 57.14% 66.31%
Cash From Operating Activities -$100.1M $21.59M
YoY Change 70.86% -88.72%
INVESTING ACTIVITIES
Capital Expenditures $17.57M $5.922M
YoY Change 351.32% 22.86%
Acquisitions
YoY Change
Other Investing Activities -$5.467M -$58.67M
YoY Change -77.01% 38496.05%
Cash From Investing Activities -$23.04M -$64.59M
YoY Change -16.74% 208.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 107.3M -54.75M
YoY Change 207.35% -6.07%
NET CHANGE
Cash From Operating Activities -100.1M 21.59M
Cash From Investing Activities -23.04M -64.59M
Cash From Financing Activities 107.3M -54.75M
Net Change In Cash -15.79M -97.74M
YoY Change -69.23% -187.18%
FREE CASH FLOW
Cash From Operating Activities -$100.1M $21.59M
Capital Expenditures $17.57M $5.922M
Free Cash Flow -$117.6M $15.67M
YoY Change 88.34% -91.6%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001576940
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q4 us-gaap Derivative Asset Statement Of Financial Position Extensible Enumeration
DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2023#PrepaidExpenseAndOtherAssets
CY2024Q1 us-gaap Derivative Asset Statement Of Financial Position Extensible Enumeration
DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2023#PrepaidExpenseAndOtherAssets
CY2023Q4 us-gaap Derivative Liability Statement Of Financial Position Extensible Enumeration
DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2023#AccruedLiabilitiesAndOtherLiabilities
CY2024Q1 us-gaap Derivative Liability Statement Of Financial Position Extensible Enumeration
DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2023#AccruedLiabilitiesAndOtherLiabilities
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
CY2023Q4 us-gaap Line Of Credit
LineOfCredit
CY2024Q1 us-gaap Line Of Credit
LineOfCredit
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
CY2024Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
001-36491
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
Century Communities, Inc.
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
68-0521411
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
8390 East Crescent Parkway
CY2024Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 650
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Greenwood Village
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CO
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
80111
CY2024Q1 dei City Area Code
CityAreaCode
303
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
770-8300
CY2024Q1 dei Security12b Title
Security12bTitle
Common stock, par value $0.01 per share
CY2024Q1 dei Trading Symbol
TradingSymbol
CCS
CY2024Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
31790755
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
122840000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
226150000
CY2024Q1 ccs Cash Held In Escrow
CashHeldInEscrow
84776000
CY2023Q4 ccs Cash Held In Escrow
CashHeldInEscrow
101845000
CY2024Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
65995000
CY2023Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
76213000
CY2024Q1 us-gaap Inventory Operative Builders
InventoryOperativeBuilders
3107133000
CY2023Q4 us-gaap Inventory Operative Builders
InventoryOperativeBuilders
3016641000
CY2024Q1 us-gaap Mortgages Held For Sale Fair Value Disclosure
MortgagesHeldForSaleFairValueDisclosure
217702000
CY2023Q4 us-gaap Mortgages Held For Sale Fair Value Disclosure
MortgagesHeldForSaleFairValueDisclosure
251852000
CY2024Q1 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
388801000
CY2023Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
350193000
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
74647000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
69075000
CY2024Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
17601000
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
16998000
CY2024Q1 us-gaap Goodwill
Goodwill
32082000
CY2023Q4 us-gaap Goodwill
Goodwill
30395000
CY2024Q1 us-gaap Assets
Assets
4111577000
CY2023Q4 us-gaap Assets
Assets
4139362000
CY2024Q1 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
135784000
CY2023Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
147265000
CY2024Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
274308000
CY2023Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
303392000
CY2024Q1 us-gaap Notes Payable
NotesPayable
1069762000
CY2023Q4 us-gaap Notes Payable
NotesPayable
1062471000
CY2024Q1 us-gaap Warehouse Agreement Borrowings
WarehouseAgreementBorrowings
212447000
CY2023Q4 us-gaap Warehouse Agreement Borrowings
WarehouseAgreementBorrowings
239298000
CY2024Q1 us-gaap Liabilities
Liabilities
1692301000
CY2023Q4 us-gaap Liabilities
Liabilities
1752426000
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31790585
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31790585
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31774615
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31774615
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
318000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
318000
CY2024Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
569581000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
592989000
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1849377000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1793629000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
2419276000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
2386936000
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4111577000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4139362000
CY2024Q1 us-gaap Revenues
Revenues
948543000
CY2023Q1 us-gaap Revenues
Revenues
752990000
CY2024Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
114109000
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
98313000
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-9630000
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1498000
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
84320000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
44009000
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
19988000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10698000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
64332000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
33311000
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.02
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.04
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.00
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.04
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31808959
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31914414
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32238808
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32117082
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
64332000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
33311000
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5475000
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3292000
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2796000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
5360000
CY2024Q1 ccs Fair Value Of Loans Held For Sale And Other
FairValueOfLoansHeldForSaleAndOther
-2443000
CY2023Q1 ccs Fair Value Of Loans Held For Sale And Other
FairValueOfLoansHeldForSaleAndOther
205000
CY2024Q1 ccs Impairment On Other Investment
ImpairmentOnOtherInvestment
7722000
CY2024Q1 ccs Purchase Price Accounting For Acquired Work In Process Inventory
PurchasePriceAccountingForAcquiredWorkInProcessInventory
1581000
CY2024Q1 ccs Abandonment Of Lot Option Contracts
AbandonmentOfLotOptionContracts
762000
CY2023Q1 ccs Abandonment Of Lot Option Contracts
AbandonmentOfLotOptionContracts
638000
CY2024Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-603000
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-83000
CY2024Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-274000
CY2023Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-198000
CY2024Q1 ccs Increase Decrease In Cash Held In Escrow
IncreaseDecreaseInCashHeldInEscrow
-17069000
CY2023Q1 ccs Increase Decrease In Cash Held In Escrow
IncreaseDecreaseInCashHeldInEscrow
-43878000
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-10823000
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-10000
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
68001000
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-90152000
CY2024Q1 us-gaap Increase Decrease In Mortgage Loans Held For Sale
IncreaseDecreaseInMortgageLoansHeldForSale
-29118000
CY2023Q1 us-gaap Increase Decrease In Mortgage Loans Held For Sale
IncreaseDecreaseInMortgageLoansHeldForSale
-48241000
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
7050000
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-8247000
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-11592000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-401000
CY2024Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-28671000
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-41714000
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
21592000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
191334000
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5922000
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4820000
CY2024Q1 ccs Expenditures Related To Development Of Rental Properties
ExpendituresRelatedToDevelopmentOfRentalProperties
25950000
CY2023Q1 ccs Expenditures Related To Development Of Rental Properties
ExpendituresRelatedToDevelopmentOfRentalProperties
16268000
CY2024Q1 ccs Payments For Business Combination And Other Investing Activities
PaymentsForBusinessCombinationAndOtherInvestingActivities
32716000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
44009000
CY2023Q1 ccs Payments For Business Combination And Other Investing Activities
PaymentsForBusinessCombinationAndOtherInvestingActivities
-152000
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-64588000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-20936000
CY2024Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
211000000
CY2024Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
211000000
CY2024Q1 us-gaap Proceeds From Construction Loans Payable
ProceedsFromConstructionLoansPayable
15972000
CY2023Q1 us-gaap Proceeds From Construction Loans Payable
ProceedsFromConstructionLoansPayable
7137000
CY2024Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
11166000
CY2023Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
3032000
CY2024Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
20245000
CY2023Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
3364000
CY2024Q1 ccs Net Proceeds Payments For Mortgage Repurchase Facilities
NetProceedsPaymentsForMortgageRepurchaseFacilities
-26851000
CY2023Q1 ccs Net Proceeds Payments For Mortgage Repurchase Facilities
NetProceedsPaymentsForMortgageRepurchaseFacilities
-47842000
CY2024Q1 us-gaap Payments For Repurchase Of Other Equity
PaymentsForRepurchaseOfOtherEquity
10415000
CY2023Q1 us-gaap Payments For Repurchase Of Other Equity
PaymentsForRepurchaseOfOtherEquity
9880000
CY2024Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
16109000
CY2024Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
8264000
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
7365000
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-54746000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-58282000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-97742000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
112116000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
242003000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
308492000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
144261000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
420608000
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
122840000
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
405722000
CY2024Q1 us-gaap Restricted Cash
RestrictedCash
21421000
CY2023Q1 us-gaap Restricted Cash
RestrictedCash
14886000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
144261000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
420608000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
2386936000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
-10415000
CY2024Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
16109000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2796000
CY2024Q1 ccs Cash Dividends Declared And Dividend Equivalents
CashDividendsDeclaredAndDividendEquivalents
-8264000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
64332000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
2419276000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
2150215000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
-9880000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5360000
CY2023Q1 ccs Cash Dividends Declared And Dividend Equivalents
CashDividendsDeclaredAndDividendEquivalents
-7365000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
33311000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
2171641000
CY2024Q1 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
18
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
5
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Use of Estimates</span><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Accordingly, actual results could differ from those estimates. </span></p>
CY2024Q1 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
18
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
5
CY2024Q1 us-gaap Revenues
Revenues
948543000
CY2023Q1 us-gaap Revenues
Revenues
752990000
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
84320000
CY2024Q1 us-gaap Assets
Assets
4111577000
CY2023Q4 us-gaap Assets
Assets
4139362000
CY2024Q1 us-gaap Inventory Homes Under Construction
InventoryHomesUnderConstruction
1386300000
CY2023Q4 us-gaap Inventory Homes Under Construction
InventoryHomesUnderConstruction
1334584000
CY2024Q1 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
1645661000
CY2023Q4 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
1609459000
CY2024Q1 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
75172000
CY2023Q4 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
72598000
CY2024Q1 us-gaap Inventory Operative Builders
InventoryOperativeBuilders
3107133000
CY2023Q4 us-gaap Inventory Operative Builders
InventoryOperativeBuilders
3016641000
CY2024Q1 us-gaap Mortgages Held For Sale Fair Value Disclosure
MortgagesHeldForSaleFairValueDisclosure
217700000
CY2023Q4 us-gaap Mortgages Held For Sale Fair Value Disclosure
MortgagesHeldForSaleFairValueDisclosure
251900000
CY2024Q1 us-gaap Prepaid Insurance
PrepaidInsurance
36824000
CY2023Q4 us-gaap Prepaid Insurance
PrepaidInsurance
37624000
CY2024Q1 ccs Lot Option And Escrow Deposits
LotOptionAndEscrowDeposits
64117000
CY2023Q4 ccs Lot Option And Escrow Deposits
LotOptionAndEscrowDeposits
51369000
CY2024Q1 ccs Performance Deposits
PerformanceDeposits
8734000
CY2023Q4 ccs Performance Deposits
PerformanceDeposits
10170000
CY2024Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
21421000
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
15853000
CY2024Q1 ccs Multi Family Rental Properties Under Construction
MultiFamilyRentalPropertiesUnderConstruction
160213000
CY2023Q4 ccs Multi Family Rental Properties Under Construction
MultiFamilyRentalPropertiesUnderConstruction
136300000
CY2024Q1 ccs Mortgage Loans Held For Investment Fair Value
MortgageLoansHeldForInvestmentFairValue
21620000
CY2023Q4 ccs Mortgage Loans Held For Investment Fair Value
MortgageLoansHeldForInvestmentFairValue
21041000
CY2024Q1 ccs Mortgage Loans Held For Investment Amortized Cost
MortgageLoansHeldForInvestmentAmortizedCost
6778000
CY2023Q4 ccs Mortgage Loans Held For Investment Amortized Cost
MortgageLoansHeldForInvestmentAmortizedCost
6826000
CY2024Q1 us-gaap Servicing Asset At Fair Value Amount
ServicingAssetAtFairValueAmount
32734000
CY2023Q4 us-gaap Servicing Asset At Fair Value Amount
ServicingAssetAtFairValueAmount
30932000
CY2024Q1 us-gaap Derivative Assets
DerivativeAssets
3790000
CY2023Q4 us-gaap Derivative Assets
DerivativeAssets
1618000
CY2024Q1 us-gaap Other Assets
OtherAssets
32570000
CY2023Q4 us-gaap Other Assets
OtherAssets
38460000
CY2024Q1 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
388801000
CY2023Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
350193000
CY2024Q1 us-gaap Customer Advances And Deposits
CustomerAdvancesAndDeposits
14402000
CY2023Q4 us-gaap Customer Advances And Deposits
CustomerAdvancesAndDeposits
7933000
CY2024Q1 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
11212000
CY2023Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
11524000
CY2024Q1 us-gaap Self Insurance Reserve
SelfInsuranceReserve
25652000
CY2023Q4 us-gaap Self Insurance Reserve
SelfInsuranceReserve
23659000
CY2024Q1 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
33657000
CY2023Q4 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
80133000
CY2024Q1 us-gaap Construction Payable Current And Noncurrent
ConstructionPayableCurrentAndNoncurrent
121314000
CY2023Q4 us-gaap Construction Payable Current And Noncurrent
ConstructionPayableCurrentAndNoncurrent
120224000
CY2024Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
14324000
CY2023Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
10404000
CY2024Q1 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
8464000
CY2024Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
979000
CY2023Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
5291000
CY2024Q1 us-gaap Other Liabilities
OtherLiabilities
44304000
CY2023Q4 us-gaap Other Liabilities
OtherLiabilities
44224000
CY2024Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
274308000
CY2023Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
303392000
CY2024Q1 us-gaap Standard Product Warranty Accrual Period Increase Decrease
StandardProductWarrantyAccrualPeriodIncreaseDecrease
-1300000
CY2023Q1 us-gaap Standard Product Warranty Accrual Period Increase Decrease
StandardProductWarrantyAccrualPeriodIncreaseDecrease
-500000
CY2024Q1 us-gaap Warehouse Agreement Borrowings
WarehouseAgreementBorrowings
212447000
CY2023Q4 us-gaap Warehouse Agreement Borrowings
WarehouseAgreementBorrowings
239298000
CY2023Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
11524000
CY2022Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
13136000
CY2024Q1 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
2670000
CY2023Q1 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
1829000
CY2024Q1 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
1691000
CY2023Q1 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
2176000
CY2024Q1 us-gaap Standard Product Warranty Accrual Period Increase Decrease
StandardProductWarrantyAccrualPeriodIncreaseDecrease
-1291000
CY2023Q1 us-gaap Standard Product Warranty Accrual Period Increase Decrease
StandardProductWarrantyAccrualPeriodIncreaseDecrease
-458000
CY2024Q1 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
11212000
CY2023Q1 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
12331000
CY2023Q1 ccs Self Insurance Adjustment
SelfInsuranceAdjustment
0
CY2024Q1 ccs Self Insurance Adjustment
SelfInsuranceAdjustment
0
CY2023Q4 us-gaap Self Insurance Reserve
SelfInsuranceReserve
23659000
CY2022Q4 us-gaap Self Insurance Reserve
SelfInsuranceReserve
16998000
CY2024Q1 ccs Self Insurance Expense Provisions
SelfInsuranceExpenseProvisions
2511000
CY2023Q1 ccs Self Insurance Expense Provisions
SelfInsuranceExpenseProvisions
2115000
CY2024Q1 ccs Payments For Self Insurance
PaymentsForSelfInsurance
-518000
CY2023Q1 ccs Payments For Self Insurance
PaymentsForSelfInsurance
-37000
CY2024Q1 us-gaap Self Insurance Reserve
SelfInsuranceReserve
25652000
CY2023Q1 us-gaap Self Insurance Reserve
SelfInsuranceReserve
19076000
CY2024Q1 us-gaap Notes Payable
NotesPayable
1069762000
CY2023Q4 us-gaap Notes Payable
NotesPayable
1062471000
CY2024Q1 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
1282209000
CY2023Q4 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
1301769000
CY2024Q1 us-gaap Warehouse Agreement Borrowings
WarehouseAgreementBorrowings
212400000
CY2023Q4 us-gaap Warehouse Agreement Borrowings
WarehouseAgreementBorrowings
239300000
CY2023Q4 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
72598000
CY2022Q4 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
61775000
CY2024Q1 us-gaap Real Estate Inventory Capitalized Interest Costs Incurred
RealEstateInventoryCapitalizedInterestCostsIncurred
14607000
CY2023Q1 us-gaap Real Estate Inventory Capitalized Interest Costs Incurred
RealEstateInventoryCapitalizedInterestCostsIncurred
14016000
CY2024Q1 us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
12033000
CY2023Q1 us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
9807000
CY2024Q1 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
75172000
CY2023Q1 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
65984000
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.250
CY2024Q1 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-0.013
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
20000000.0
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10700000
CY2024Q1 ccs Mortgage Servicing Cost To Service
MortgageServicingCostToService
0.072
CY2023 ccs Mortgage Servicing Cost To Service
MortgageServicingCostToService
0.072
CY2023Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2024Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2800000
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5400000
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000.0
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000.0
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31800000
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31800000
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31800000
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31800000
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q4 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
4500000
CY2024Q1 us-gaap Treasury Stock Shares Retired
TreasuryStockSharesRetired
186900
CY2024Q1 us-gaap Treasury Stock Retired Cost Method Amount
TreasuryStockRetiredCostMethodAmount
16100000
CY2024Q1 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
86.16
CY2023Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0
CY2024Q1 us-gaap Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
1043123
CY2024Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
10400000
CY2023Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
9900000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
64332000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
33311000
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31808959
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31914414
CY2024Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
429849
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
202668
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32238808
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32117082
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.02
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.04
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.00
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.04
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
500000
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
500000
CY2024Q1 ccs Land Development Performance Obligations Letters Of Credit And Performance Bonds
LandDevelopmentPerformanceObligationsLettersOfCreditAndPerformanceBonds
509000000.0
CY2023Q4 ccs Land Development Performance Obligations Letters Of Credit And Performance Bonds
LandDevelopmentPerformanceObligationsLettersOfCreditAndPerformanceBonds
510500000
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001576940-24-000037-index-headers.html Edgar Link pending
0001576940-24-000037-index.html Edgar Link pending
0001576940-24-000037.txt Edgar Link pending
0001576940-24-000037-xbrl.zip Edgar Link pending
ccs-20240331.xsd Edgar Link pending
ccs-20240331x10q.htm Edgar Link pending
ccs-20240331xex10_1.htm Edgar Link pending
ccs-20240331xex10_2.htm Edgar Link pending
ccs-20240331x10q_htm.xml Edgar Link completed
ccs-20240331xex22_1.htm Edgar Link pending
ccs-20240331xex31_1.htm Edgar Link pending
ccs-20240331xex31_2.htm Edgar Link pending
ccs-20240331xex31_3.htm Edgar Link pending
ccs-20240331xex32_1.htm Edgar Link pending
ccs-20240331xex32_2.htm Edgar Link pending
ccs-20240331xex32_3.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
ccs-20240331_def.xml Edgar Link unprocessable
ccs-20240331_lab.xml Edgar Link unprocessable
ccs-20240331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ccs-20240331_cal.xml Edgar Link unprocessable